Compared to vehicle and AAV8-scrambled shRNA controls, AAV8-Ephx2 shRNA delivery significantly reduced CNV. In addition, gene expression analysis showed reduced Vegfc and inflammatory markers Tnf伪, Il1尾, and Vcam1 but increased cytoprotective Hmox1 in the AAV8-Ephx2 shRNA treatment group ...